Company Overview of ZyStor Therapeutics, Inc.
ZyStor Therapeutics, Inc., a biotechnology company, develops therapeutics for patients with genetic disorders. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was formerly known as Symbiontics, Inc. ZyStor Therapeutics, Inc. was incorporated in 2004 and is based in Milwaukee, Wisconsin. As of August 17, 2010, ZyStor Therapeutics, Inc. operates as a subsidiary of BioMarin Pharmaceutical Inc.
10437 Innovation Drive
Milwaukee, WI 53226-4838
Founded in 2004
Key Executives for ZyStor Therapeutics, Inc.
Similar Private Companies By Industry
|Boval Company, LP||United States|
|Skinetics Biosciences, Inc.||United States|
|Avicena Group, Inc.||United States|
|Tetracore, Inc.||United States|
|New Century Pharmaceuticals, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ZyStor Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.